CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,887 | -60.6% | 298,373 | -39.9% | 0.00% | -100.0% |
| Q2 2023 | $5,175,604 | +193.7% | 496,699 | +96.5% | 0.00% | – |
| Q1 2023 | $1,761,939 | +119.2% | 252,789 | +89.6% | 0.00% | – |
| Q4 2022 | $803,799 | -66.3% | 133,300 | -56.0% | 0.00% | – |
| Q3 2022 | $2,386,000 | -72.8% | 302,801 | -53.1% | 0.00% | -100.0% |
| Q2 2022 | $8,780,000 | -38.2% | 645,147 | -10.9% | 0.00% | +50.0% |
| Q1 2022 | $14,204,000 | -76.8% | 724,269 | -59.4% | 0.00% | 0.0% |
| Q4 2021 | $61,268,000 | +16.2% | 1,785,666 | +85.0% | 0.00% | -71.4% |
| Q3 2021 | $52,725,000 | -60.2% | 965,304 | -46.5% | 0.01% | -61.1% |
| Q2 2021 | $132,514,000 | +30.5% | 1,803,399 | +62.4% | 0.02% | +5.9% |
| Q1 2021 | $101,579,000 | +24.0% | 1,110,638 | +9.9% | 0.02% | +142.9% |
| Q4 2020 | $81,922,000 | +248.4% | 1,010,494 | +100.0% | 0.01% | +40.0% |
| Q3 2020 | $23,515,000 | – | 505,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |